Correct Answer: D. GM2 ganglioside
Tay-Sachs disease is caused by deficiency of hexosaminidase A (Hex-A), an enzyme responsible for degrading GM2 ganglioside. The cherry red spot on fundus examination is a pathognomonic sign—it represents retinal whitening due to ganglioside accumulation in retinal neurons, with the fovea appearing red because it lacks ganglioside-laden cells. Hex-A catalyzes the removal of N-acetylgalactosamine from GM2 ganglioside; without this enzyme, GM2 accumulates in neurons, lysosomes, and retinal cells. The disease presents in infants (typically 3–6 months) with developmental regression, seizures, hypotonia, and blindness. GM2 ganglioside is a sphingolipid with a complex structure containing a ceramide backbone, oligosaccharide chain, and sialic acid residues. Accumulation in the CNS causes progressive neuronal dysfunction. This is distinct from other lysosomal storage disorders: GM1 gangliosidosis (GM1 accumulation, β-galactosidase deficiency), Gaucher disease (glucocerebroside, glucocerebrosidase deficiency), and Niemann-Pick disease (sphingomyelin, sphingomyelinase deficiency). The clinical triad of cherry red spot + seizures + developmental regression in an infant is virtually diagnostic of Tay-Sachs in the Indian population, where consanguinity increases carrier frequency.
Why the other options are wrong
A. Glucocerebroside — Glucocerebroside accumulates in Gaucher disease (β-glucocerebrosidase deficiency), not Tay-Sachs. Gaucher disease presents with hepatosplenomegaly and bone involvement, NOT cherry red spot or acute neonatal seizures. This is a common trap—students confuse lysosomal storage disorders by substrate rather than enzyme. B. Sphingomyelin — Sphingomyelin accumulates in Niemann-Pick disease (sphingomyelinase deficiency), which presents with hepatosplenomegaly and pulmonary involvement. While Niemann-Pick can cause neurological symptoms, it does NOT produce the characteristic cherry red spot seen in Tay-Sachs. The fundoscopic finding is the key discriminator here. C. GM1 ganglioside — GM1 gangliosidosis results from β-galactosidase deficiency, not Hex-A deficiency. Although GM1 gangliosidosis also presents with infantile seizures and developmental regression, it typically includes coarse facial features and skeletal abnormalities (unlike Tay-Sachs), and the cherry red spot is less characteristic. Hex-A deficiency specifically causes GM2 accumulation.
High-Yield Facts
- Tay-Sachs disease = Hexosaminidase A deficiency → GM2 ganglioside accumulation in CNS and retina.
- Cherry red spot on fundus is pathognomonic for Tay-Sachs; represents retinal whitening with spared fovea due to ganglioside deposition.
- Infantile presentation: seizures, developmental regression, blindness, hypotonia by 3–6 months; death by age 3–4 years.
- Autosomal recessive inheritance; higher carrier frequency in Ashkenazi Jewish and some Indian populations due to consanguinity.
- Hex-A enzyme cleaves N-acetylgalactosamine from GM2 ganglioside; deficiency → lysosomal accumulation in neurons.
- Prenatal diagnosis via amniocentesis (low Hex-A activity) and genetic counseling are critical in high-risk families in India.
Mnemonics
Cherry Red Spot = Tay-Sachs (CRS-TS) Cherry Red Spot → Tay-Sachs. When you see cherry red spot + seizures + regression in an infant, think Hex-A deficiency and GM2 accumulation immediately. Ganglioside Storage Diseases (GSDs) GM2 (Tay-Sachs, Hex-A) | GM1 (β-galactosidase) | Sphingomyelin (Niemann-Pick) | Glucocerebroside (Gaucher). Match enzyme deficiency to substrate, not just the disease name.
NBE Trap
NBE pairs "cherry red spot" with multiple gangliosidoses to trap students who don't recall that Tay-Sachs (Hex-A deficiency → GM2) is the ONLY one with this pathognomonic fundoscopic sign. Confusing GM1 gangliosidosis (which has coarse features, not cherry red spot) is the most common error.
Clinical Pearl
In Indian pediatric practice, Tay-Sachs should be suspected in any neonate with seizures + developmental regression + cherry red spot, especially in families with consanguinity. Early enzyme assay (Hex-A activity in leukocytes or fibroblasts) confirms diagnosis; genetic counseling and prenatal diagnosis in subsequent pregnancies are essential given the autosomal recessive inheritance and high carrier frequency in certain Indian communities.
_Reference: Robbins Ch. 5 (Lysosomal Storage Diseases); Harrison Ch. 349 (Lysosomal Disorders); KD Tripathi Ch. 37 (Lipid Metabolism & Storage Disorders)_